New Frontiers in the Treatment and Management of Amyotrophic Lateral Sclerosis (ALS): Managed Care Considerations in an Evolving Treatment Paradigm

A continuing medical education activity provided by NAMCP and AAMCN

This activity is an archive from the live session from the 2020 Spring Managed Care Forum. If you participated in the live session, you are not eligible for continuing education credits from this archive.

This activity is valid from August 1, 2020 to August 1, 2021

Instructions for CME/NCPD: Complete the pre-test, listen to the audio and view the slides, complete the post test, complete the evaluation form and hit submit. You will be asked to enter your name and email address on the pre-test, evaluation and post-test. If you close your internet browser without completing the post test, you will have ONE more opportunity to complete. A score of 70% must be achieved on the post test to receive continuing education credits. If you do not pass the post test after two attempts, you will not be eligible to try again. Once you complete the evaluation form and score 70% or higher on your post test, you will automatically be given your certificate.

To print or save your certificate, you will need to click on the “download” button and either print or save.

 

Audience: This activity is intended for healthcare professionals practicing in managed care environments.

This activity is supported by an educational grant from
Biogen and Mitsubishi Tanabe Pharma America

Description:
Amyotrophic lateral sclerosis (ALS), more commonly known as Lou Gehrig’s disease, is a progressive neurodegenerative disease that affects nerve cells in the brain and the spinal cord. ALS is a progressive disease in which the motor neurons eventually die and mortality is usually the result of respiratory failure. As there is no current cure for ALS, management focuses on treating symptoms and providing supportive care, with the goal of improving quality of life and prolonging survival in patients. This care is best provided by multidisciplinary teams of healthcare professionals; attending a multidisciplinary ALS clinic is associated with longer survival, fewer hospitalizations, and improved quality of life as they have access to the most recent treatments and management tools. Fortunately new agents have recently become available, or are undergoing clinical trials, that have shown the ability to slow functional decline in with ALS, giving providers and payers even more options to manage these populations and improve quality of life.

Upon completion of this activity, participants will be able to:

  • Assess the impact, direct and indirect costs, and unmet needs of amyotrophic lateral sclerosis (ALS) and the value of early diagnosis

  • Explain the disease progression of ALS and the benefit of early recognition

  • Differentiate among the mechanisms of action, efficacy, and safety for currently approved treatments in ALS

  • Investigate multidisciplinary care approaches to treating patients with ALS and optimize the management of symptoms associated with ALS with novel treatment strategies

  • Employ resource utilization management strategies that support patient needs and are cost-effective

  • Identify methods to navigate access to appropriate ALS therapies and discuss managed care considerations around those therapies


     

Faculty: Robert L. Sufit, MD
Professor of Neurology and Surgery
Northwestern University Feinberg School of Medicine

Disclosure:

Dr. Sufit has no relevant financial relationships to disclose.
  Planning Committee:
Bill Williams, MD has no real or perceived financial relationships to disclose.
Jeremy Williams has no real or perceived financial relationships to disclose.
Jacqueline Cole, RN, MS, CMCN has no real or perceived financial relationships to disclose.

NAMCP and/or the presenter has copyright or has received permissions for use of materials provided in this activity.

Accreditation & Designation
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association of Managed Care Physicians (NAMCP) and American Association of Managed Care Nurses (AAMCN). The National Association of Managed Care Physicians is accredited by the ACCME to provide continuing medical education for physicians.

NAMCP designates this enduring material for a maximum of 1 AMA PRA Category 1 credit(s)TM. Each
physician should claim credit commensurate with the extent of their participation in the activity.

The American Association of Managed Care Nurses is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.

Nurses who complete this activity and achieve a passing score will receive 1 hour in nursing continuing professional development.

This activity has been approved by the American Board of Managed Care Nursing for 1.0 contact hours toward CMCN recertification requirements.

This activity is supported by an educational grant from
Biogen and Mitsubishi Tanabe Pharma America

NAMCP and/or this website does not provide medical advice, diagnosis or treatment. NAMCP does not endorse or imply endorsement of the content on any linked website. This website is to be used as an informational resource. With any health related concern, consult with your physician or healthcare professional.

Click Here To Continue